F.D.A. Did Not Intervene to Curb Risky Fentanyl Prescriptions
Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs.
Source: NYT Health - Category: Consumer Health News Authors: EMILY BAUMGAERTNER Tags: Opioids and Opiates Drugs (Pharmaceuticals) Food and Drug Administration Fentanyl McKesson Corporation Labeling and Labels (Product) Insys Therapeutics Inc Johns Hopkins University Cephalon Inc Source Type: news
More News: Cancer | Cancer & Oncology | Fentanyl | Food and Drug Administration (FDA) | Health | John Hopkins University | Pain